Biochip analysis of prostate cancer.
Microarray expression analysis was used to forecast the roles of differentially co-expressed genes (DCG) and DCG and links in the pathogenesis of prostate cancer. In addition, we demonstrate that the relationship between transcriptional factors (TFs) and their targets can be considered a key factor in determining the difference between primary and metastatic prostate cancer. Regulatory impact factors were adopted to calculate the impact of TF. We identified 5 TFs and 29 target genes important in the transition between normal prostate and primary prostate cancer and 2 TFs and 7 target genes important in the transition between primary and metastatic prostate cancer. These results suggest that it may be possible to predict the clinical behavior of prostate cancer based on gene expression analysis.
Department II of Urology, XinQiao Hospital, Third Military Medical University, Chongqing, China.
M Q
MQ
Fan
Department II of Urology, XinQiao Hospital, Third Military Medical University, Chongqing, China.
P X
PX
Wang
Department II of Urology, XinQiao Hospital, Third Military Medical University, Chongqing, China.
J Y
JY
Feng
Department II of Urology, XinQiao Hospital, Third Military Medical University, Chongqing, China.
Y
Y
Xiao
Department II of Urology, XinQiao Hospital, Third Military Medical University, Chongqing, China chenhaigechg@hotmail.com.
C B
CB
Huang
D014408:Biomarkers, Tumor / Q000235:genetics* / Q000378:metabolism; D020869:Gene Expression Profiling; D053263:Gene Regulatory Networks; D006801:Humans; D008297:Male; D020411:Oligonucleotide Array Sequence Analysis; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000378:metabolism; D014157:Transcription Factors / Q000235:genetics* / Q000378:metabolism
D014408:Biomarkers, Tumor; D014157:Transcription Factors